37 results
8-K
EX-99.1
PTCT
PTC Therapeutics Inc
25 Apr 24
Results of Operations and Financial Condition
4:10pm
of the reduction in workforce in 2023.
Non-GAAP SG&A expenses were $63.9 million for the first quarter of 2024, excluding $9.4 million in non-cash, stock … ; the extent, timing and financial aspects of our strategic pipeline prioritization and reductions in workforce; and the objectives of management. Other forward
8-K
EX-99.1
PTCT
PTC Therapeutics Inc
29 Feb 24
Results of Operations and Financial Condition
4:15pm
for the fourth quarter of 2023 was primarily due to lower employee costs as a result of the reduction in workforce. The increase in SG&A expense for full … costs from the reduction in workforce in the year ended December 31, 2023.
Non-GAAP SG&A expense was $67.9 million for the fourth quarter of 2023
8-K
EX-99.2
4644f19g lqik2yu3
8 Jan 24
Results of Operations and Financial Condition
9:27am
8-K
EX-99.1
irpl6jhnv5 pk7vchq5q
8 Jan 24
Results of Operations and Financial Condition
9:27am
8-K
EX-99.1
x7fh7axuxtl4c9u
26 Oct 23
Results of Operations and Financial Condition
4:07pm
8-K
EX-99.1
yy13lq e3j8hx71yv20k
28 Sep 23
PTC Announces Further Strategic Prioritization and Associated Reduction in Workforce
4:45pm
8-K
2ew5l58p9zu
28 Sep 23
PTC Announces Further Strategic Prioritization and Associated Reduction in Workforce
4:45pm
8-K
EX-99.1
2y23n
3 Aug 23
Results of Operations and Financial Condition
4:03pm
8-K
l3ywwzb4h
23 May 23
PTC Therapeutics Announces Strategic Pipeline Prioritization
5:17pm
8-K
EX-99.1
txp6l4tao33cvt 98
23 May 23
PTC Therapeutics Announces Strategic Pipeline Prioritization
5:17pm